Allergan Ophthalmic Products Spin-Off Creates $500 Mil. Device Company
This article was originally published in The Gray Sheet
Executive Summary
Advanced Medical Optics' plan to develop a phakic intraocular lens (IOL) based on Ophtec BV's Artisan lens technology exemplifies the types of strategic alliance to be highlighted by AMO following its spin-off from Allergan in July
You may also be interested in...
Allergan Eyes Edema, Macular Degeneration Indications With Oculex Buy
Allergan could enter the retinal therapy market in late 2006 with Oculex' macular edema implant Posurdex, following its $230 mil. acquisition of the tech firm
Allergan Eyes Edema, Macular Degeneration Indications With Oculex Buy
Allergan could enter the retinal therapy market in late 2006 with Oculex' macular edema implant Posurdex, following its $230 mil. acquisition of the tech firm
Ophthalmic Spin-Offs Alcon, AMO See Stock Gains In 2002, Join MDDI Index
Ophthalmic device makers Alcon and Advanced Medical Optics (AMO) were both able to achieve double-digit stock price percentage gains in 2002 after debuting as independent firms, in part due to expanding sales of surgical products such as IOLs